GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Equity-to-Asset

Oxygenta Pharmaceutical (BOM:524636) Equity-to-Asset : -0.32 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Oxygenta Pharmaceutical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹-201.2 Mil. Oxygenta Pharmaceutical's Total Assets for the quarter that ended in Mar. 2024 was ₹631.9 Mil. Therefore, Oxygenta Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was -0.32.

The historical rank and industry rank for Oxygenta Pharmaceutical's Equity-to-Asset or its related term are showing as below:

BOM:524636' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.2   Med: -1.12   Max: -0.32
Current: -0.32

During the past 13 years, the highest Equity to Asset Ratio of Oxygenta Pharmaceutical was -0.32. The lowest was -2.20. And the median was -1.12.

BOM:524636's Equity-to-Asset is ranked worse than
91.54% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:524636: -0.32

Oxygenta Pharmaceutical Equity-to-Asset Historical Data

The historical data trend for Oxygenta Pharmaceutical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Equity-to-Asset Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.20 -1.12 -1.11 -0.85 -0.32

Oxygenta Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 - -0.38 - -0.32

Competitive Comparison of Oxygenta Pharmaceutical's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Equity-to-Asset falls into.



Oxygenta Pharmaceutical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Oxygenta Pharmaceutical's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=-201.224/631.921
=-0.32

Oxygenta Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=-201.224/631.921
=-0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxygenta Pharmaceutical  (BOM:524636) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Oxygenta Pharmaceutical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxygenta Pharmaceutical (BOM:524636) Business Description

Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines